NuScale Power (NYSE: SMR) has captured significant attention from Wall Street analysts, with a consensus price target of $11.85 implying nearly 30% upside from current levels.
Two analysts covering the stock believe shares could double in value over the next 12 months, reflecting broad optimism about the company’s positioning in the nuclear energy sector.
NuScale remains the only company in the United States that has received regulatory clearance to construct a small modular reactor (SMR) system, giving it a meaningful first-mover advantage.
While competitors are currently working through the regulatory application pipeline, NuScale’s unique cleared status, combined with artificial intelligence’s rapidly rising energy demands, has fueled an optimistic outlook.
The long-term demand picture for nuclear energy is substantial, with Bank of America estimating it will represent a $10 trillion global opportunity through 2050.
However, Bank of America also projects that SMRs will account for a minority share of that opportunity, with meaningful adoption not expected to arrive until 2035 or later.
NuScale has several major projects already in its pipeline, including a 6-gigawatt deal signed with financing partner ENTRA1 and the Tennessee Valley Authority, a northeastern utility.
The company’s chief financial officer has guided investors to expect a power purchase agreement on its flagship 6-gigawatt U.S. project by the end of 2026, a milestone that would clear the path for construction to begin.
A signed power purchase agreement would carry significant weight for both NuScale’s operational prospects and its stock price, representing a concrete step toward revenue generation.
The downside scenario, however, carries serious consequences, as NuScale remains unprofitable and any delay to its most promising project would likely force the company to raise additional capital through share issuance.
That share dilution risk is the critical factor analysts appear to be underweighting, with existing shareholders potentially facing meaningful erosion of their ownership stakes during what is expected to be a long commercialization runway.
Investors drawn to NuScale’s long-term potential should weigh the company’s regulatory edge and pipeline strength against the near-term financial pressures that could test their patience and dilute their returns along the way.
